Anthropic’s Dario Amodei defends AI warnings, says public backlash reflects ‘crisis in trust’

Anthropic CEO Dario Amodei defended his AI risk warnings against investor Gavin Baker's criticism, arguing that public backlash reflects a 'crisis in trust' rather than messaging problems. Amodei acknowledged that AI companies, including Anthropic, have not yet delivered on promises to benefit the world, and rejected the view that regulation always leads to regulatory capture. The exchange highlights a split among Silicon Valley figures over AI regulation and deployment.

August 19, 2026 , Inside AI — Anthropic CEO Dario Amodei pushed back this week against claims that his warnings about AI risks have fueled public backlash. Investor Gavin Baker said on the All-In podcast that Amodei has “lost the argument” on regulation and should be a more positive advocate. Amodei rejected that framing on X. He said his messaging has been balanced between risks and benefits, not disproportionately negative. The real issue, he argued, is a breakdown in public confidence. “I think it is fundamentally a crisis of trust. I think that ordinary people don't trust companies, governments, or the tech industry and always suspect that we are cooking up some new way to screw them over,” Amodei said. He also acknowledged a sharper criticism. AI companies, including Anthropic, have not yet delivered on grand promises to benefit the world. That failure, he said, is the criticism people should make, not messaging and marketing. “I think by far the most accurate criticism of AI companies including Anthropic is that we haven't yet delivered on our big promises to benefit the world. That is totally on us, and I think it's the criticism you should be making, instead of all this stuff about messaging and marketing,” he added. The exchange comes amid rising tension over data center construction in the United States. Baker said Amodei’s dire warnings have helped fuel local opposition. The dispute is not just about tone. It reflects a deeper split over whether AI’s risks justify slower deployment. Amodei has long argued that advanced AI could enable cyber attacks or help develop biological weapons. Those concerns have appeared in open letters and proposals for pauses. But he also insists AI could deliver major benefits, including helping develop a cure for cancer. On regulation, Amodei said Baker was presenting a false choice between distributing AI widely without rules or concentrating power through regulation. He rejected the Silicon Valley shorthand that regulation always equals regulatory capture. “I know that there's a sort of Silicon Valley shorthand where regulation = regulatory capture = concentration of power, but I've always found this to be an overly simplified picture of the world. Many people outside this bubble think of regulation as something that constrains corporate power and benefits ordinary people,” he said. Regulatory capture debate splits Silicon Valley voices Former White House AI czar David Sacks disagreed. He argued regulation often happens because deep-pocketed industry groups convince the government to write rules as they see fit. His response on X suggested Amodei’s defense did not hold up. OpenAI advisor Fidji Simo backed Amodei’s broader point. She said people often draw a straight line from smarter models to cures without acknowledging missing infrastructure. AI training data and infrastructure, she argued, are a bigger bottleneck than regulation. “The thing that frustrates me is that some people often draw a straight line from smarter models → cures, without acknowledging how much infrastructure is missing in between. We've still got a lot of work to do, people,” she said. Simo added that AI could cure all diseases, but only if infrastructure translates intelligence into cures at the same pace models improve. Otherwise, she warned, superintelligent AI could have an incomplete picture of human biology and delay that promise by years. The Trump administration has taken an ad-hoc approach to AI regulation since Anthropic unveiled its Claude Mythos AI model in April 2026. No tangible AI policy has emerged. That vacuum leaves companies like Anthropic to defend their positions in public debates. This is not the first time Anthropic has clashed with Silicon Valley figures over AI risk. The company maintains its concerns are justified. Critics argue repeated warnings invite government crackdowns and slow innovation. The broader tension extends beyond regulation. Anthropic recently added hidden watermarks to Claude-generated text. The move raised questions about transparency and whether such protections can be removed. It also feeds the same trust crisis Amodei described.